Stereotaxis (STXS) Income from Continuing Operations (2010 - 2026)
Stereotaxis' (STXS) quarterly Income from Continuing Operations came in at 12778000.0 in Q1 2026, down 105.34% year-on-year from 239510524.1 in Q1 2025, and down 83.49% on a QoQ basis from 6964000.0 in Q4 2025.
Stereotaxis (STXS) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has 17 years of Income from Continuing Operations data on file, last reported at 12778000.0 in Q1 2026.
- On a quarterly basis, Income from Continuing Operations fell 105.34% year-over-year to 12778000.0 in Q1 2026; TTM through Mar 2026 was 32458000.0, a 16.93% decrease from a year earlier, with the FY2025 full-year figure at 24312000.0, up 61.77% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 12778000.0, down from 6964000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for STXS reached as high as 4523000.0 in Q1 2022 and fell as low as 12778000.0 in Q1 2026.
- Historically, Income from Continuing Operations has averaged 6350705.88 across 5 years, with a median of 5861000.0 in 2023.
- Across the five-year window, Income from Continuing Operations slumped 109.5% in 2022 and gained 19.3% in 2025, its largest moves.
- Year by year, Income from Continuing Operations stood at 4696000.0 in 2022, then retreated by 18.46% to 5563000.0 in 2023, then slumped by 55.13% to 8630000.0 in 2024, then grew by 19.3% to 6964000.0 in 2025, then plunged by 83.49% to 12778000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 12778000.0 in Q1 2026, 6964000.0 in Q4 2025, and 6855000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 240.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -37.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 13.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Stereotaxis | 136.49 Mn | 121.87 Mn | 3.79 Mn | -12.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.78 Mn |
| Dec 31, 2025 | -6.96 Mn |
| Sep 30, 2025 | -6.86 Mn |
| Jun 30, 2025 | -5.86 Mn |
| Mar 31, 2025 | -6.22 Mn |
| Dec 31, 2024 | -8.63 Mn |
| Sep 30, 2024 | -6.63 Mn |
| Jun 30, 2024 | -6.27 Mn |
| Mar 31, 2024 | -5.00 Mn |
| Dec 31, 2023 | -5.56 Mn |
| Sep 30, 2023 | -5.89 Mn |
| Jun 30, 2023 | -5.52 Mn |
| Mar 31, 2023 | -5.86 Mn |
| Dec 31, 2022 | -4.70 Mn |
| Sep 30, 2022 | -5.28 Mn |
| Jun 30, 2022 | -5.40 Mn |
| Mar 31, 2022 | -4.52 Mn |
| Dec 31, 2021 | -3.78 Mn |
| Sep 30, 2021 | -5.24 Mn |
| Jun 30, 2021 | -3.93 Mn |